Interesting! Now, off you go, back to fighting off your own post-lunch sleep attack. Using an animal model, scientists have learned that this same group of neurons becomes inactive during cataplectic attacks, a discovery that provides a clue to at least one of the neurological abnormalities contributing to human narcoleptic symptoms. A group of neurons in the brain stem halts activity during REM sleep, inhibiting muscle movement. The loss of muscle tone during a cataplectic episode resembles the interruption of muscle activity that naturally occurs during REM sleep. Cataplexy can occur spontaneously, as it seems to in this video, and though it’s not clear what causes it, the National Institutes of Health offers this as explanation: In others, the weakness can be very subtle, causing just a slight drooping of the eyelids, for example. Most people who have narcolepsy, the brain disorder characterized by excessive daytime sleepiness, also have cataplexy this is that sudden muscle weakness that for this woman caused a collapse. Specifically, Mignot said, this looks like narcolepsy with cataplexy. But the sleep disorder experts Science of Us contacted, including Emmanuel Mignot, director of the Stanford Center for Sleep Sciences and Medicine, said that this really does look like narcolepsy. Her collapse and subsequent confusion seem bizarre - even slightly fake, to be honest. The YouTube clip was published in July, but is just now achieving viral status thanks to a post on Reddit over the weekend. Xyrem® was designated as an orphan medicinal product on February 3, 2003.It must be pretty darn scary to have narcolepsy, at least judging by the way it looks in this video, in which a young woman accidentally catches her own narcoleptic sleep attack on camera. by Jazz Pharmaceuticals and has been available in the U.S. In Europe, the approval of Xyrem® for the treatment of cataplexy in patients with narcolepsy provides a welcome addition to the pharmacological armamentarium."ġ. UCB acquired the licence to distribute Xyrem® in Europe from Orphan Medical recently acquired by Jazz Pharmaceuticals). Thomas Hospital, London, UK said "Patients and physicians in the EU should be encouraged by the body of clinical research supporting Xyrem®. Ĭommenting on the marketing approval Adrian Williams MD of Sleep Centre, St. It involves a sudden reversible loss of muscle tone, usually triggered by emotional stimuli such as laughter, excitement, surprise and anger, with contributing factors including physical fatigue, stress or sleepiness. Cataplexy is a typical symptom of narcolepsy and is present in 65-70% of patients with narcolepsy. Narcolepsy is a debilitating, life-long neurological disorder that is characterised by excessive daytime sleepiness and sleep attacks. We are delighted to serve European physicians and sleep centres with a product that can help fulfil the unmet medical need in patients with this serious sleep disorder." said Emmanuel Caeymaex, Vice-President, Marketing CNS, UCB. "Xyrem® provides physicians and patients in Europe with the first and only EMEA approved medication for the treatment of cataplexy in patients with narcolepsy. Launch in this first major European market follows the recent European Commission (EC) marketing approval of Xyrem® in this orphan indication, with pan-European commercialisation expected over 2006. response when the bodys immune system mistakenly attacks healthy cells. Toggle menu Neupro® - Restless Legs Syndromeīrussels, Belgium - December 8, 2005: UCB announced today that Xyrem® (sodium oxybate) oral solution is now available in Germany for the treatment of cataplexy in adult patients with narcolepsy. Narcolepsy is a chronic (ongoing) sleep disorder that causes a frequent and.Toggle menu Neupro® - Parkinson's disease.Toggle menu Cimzia® - Rheumatoid arthritis (RA).Toggle menu Cimzia® - Psoriatic arthritis (PsA).Toggle menu Cimzia® - Plaque psoriasis (PsO).Toggle menu Cimzia® - Axial spondyloarthritis (axSpA).Toggle menu Cimzia® - Ankylosing spondylitis (AS).Toggle menu Ferrous(II) glycine sulphate complex (Ferro Sanol®).Toggle menu Certolizumab Pegol (Cimzia®).Toggle menu Carbidopa,Levodopa (Parcopa®).Toggle menu Digital Business Transformation.Toggle menu Disclosure of payments to Healthcare Professionals.Toggle menu Celebrating One Year of Advantage Hers.Toggle menu The Impact of Psoriatic Disease.Cimzia® - Axial spondyloarthritis (axSpA). ![]() ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |